Glucose News and Research

RSS

Natural compound from pomegranate leaves shows promise against TTR amyloidosis

A research team in Kumamoto University has discovered that a natural compound found in pomegranate leaves and branches can directly break down harmful protein aggregates linked to transthyretin (TTR) amyloidosis, a progressive and potentially life-threatening disease affecting the nerves and heart.

23 Feb 2026

Researchers show red blood cells drive better glucose tolerance at high altitude

Chronic hypoxia improves glucose tolerance in mice through insulin-independent mechanisms, with red blood cells acting as a major systemic glucose sink. Increased erythrocyte production and altered glycolytic flux help reduce circulating glucose while supporting oxygen delivery to tissues.

22 Feb 2026

New review explores whether berries can slow cognitive decline linked to obesity

This systematic review in Nutrients evaluates human studies investigating whether polyphenol-rich berry consumption can modulate obesity-related metabolic dysfunction and support cognitive performance, particularly in individuals at risk of mild cognitive impairment. Evidence suggests modest memory benefits and possible metabolic improvements, although biomarker findings and long-term clinical relevance remain uncertain.

22 Feb 2026

Affordable microscope captures living cells during chaotic conditions of zero-gravity flight

As space agencies prepare for human missions to the Moon and Mars, scientists need to understand how the absence of gravity affects living cells.

22 Feb 2026

Should drug companies be advertising to consumers?

Tamar Abrams had a lousy couple of years in 2022 and '23. Both her parents died; a relationship ended; she retired from communications consulting.

20 Feb 2026

Low oxygen turns red blood cells into powerful glucose sinks

Scientists have long known that people living at high altitudes, where oxygen levels are low, have lower rates of diabetes than people living closer to sea level.

19 Feb 2026

Hypoxia rewires red blood cells to clear excess glucose

In a 2023 paper on hypoxia and glucose metabolism, our lab showed how organisms rewire their metabolism to adapt to low oxygen levels-such as those found at high altitudes.

19 Feb 2026

Syzygium jambolanum extract shows promise for diabetes management

The search for effective and accessible therapies for diabetes continues to draw attention to medicinal plants with a long history of traditional use.

19 Feb 2026

Gut microbiome may shape response to GLP-1 drugs, new review suggests

This review examines how GLP-1 receptor agonists and the gut microbiome influence one another through bile acid signaling, short-chain fatty acids, and inflammatory pathways. It explores how microbial composition may shape treatment response and highlights the need for controlled human studies to enable microbiome-informed precision therapy.

19 Feb 2026

Gut bacteria patterns help predict insulin resistance in type 2 diabetes, study finds

Researchers used 16S rRNA sequencing and machine learning to identify gut microbiome patterns associated with insulin resistance severity in people with type 2 diabetes. XGBoost models showed that specific bacterial genera, including Bacteroides and Faecalibacterium, help distinguish individuals with higher insulin resistance from healthy controls.

19 Feb 2026

Intermittent calorie restriction proves as effective as daily calorie cuts for type 2 diabetes

A post-hoc analysis of two clinical trials compared continuous calorie restriction with early time-restricted eating in adults with type 2 diabetes and overweight or obesity over three months. Both approaches improved weight, body composition, and metabolic health, with no clear superiority except for lower dropout with intermittent restriction.

18 Feb 2026

How GLP-1 drugs affect the body beyond weight loss and glucose control

This review evaluates the safety profile of glucagon-like peptide-1 receptor agonists and related incretin therapies used for obesity and type 2 diabetes. It highlights common gastrointestinal effects, rare but debated risks, and areas where further long-term safety data are still needed.

18 Feb 2026

Undiagnosed diabetes and kidney disease raise heart risk

Diabetes and kidney disease are major risk factors for heart disease, yet many cases are undiagnosed. In addition, a consumer survey done last fall suggests that most people don't realize that their heart, kidney and metabolic health (how the body creates, uses and stores energy) are connected.

18 Feb 2026

Can GLP-1 drugs slow neurodegeneration? New review finds promising signals but limited clinical proof

This review examines how GLP-1 receptor agonists may influence neurodegenerative disease biology through metabolic, inflammatory, mitochondrial, and proteostasis pathways. Evidence from mechanistic, preclinical, and early clinical studies suggests potential neuroprotective effects, but definitive disease-modifying benefit remains unproven.

17 Feb 2026

Study links microbe-rich diets with better insulin and cholesterol markers

This exploratory Australian study developed a database to estimate live microbe content in foods and examined associations with cardiometabolic health indicators in adults. Higher intake of foods estimated to contain live microbes was linked with favourable markers such as higher HDL cholesterol and lower BMI, insulin, and waist circumference, although causality cannot be inferred.

16 Feb 2026

Do cocoa flavanols influence heart and fatty liver risk factors?

A recent Nutrients review examined whether cocoa-rich dark chocolate influences cardiovascular and metabolic dysfunction-associated steatotic liver disease risk factors through antioxidant, anti-inflammatory, and endothelial effects. Evidence suggests modest improvements in biomarkers, but most data come from short-term studies, so definitive clinical benefits remain unproven.

16 Feb 2026

Machine learning model demonstrates insulin resistance as a risk factor for 12 types of cancer

Insulin resistance - when the body doesn't properly respond to insulin, a hormone that helps control blood glucose levels - is one of the fundamental causes of diabetes.

16 Feb 2026

Big breakfast study reveals protein curbs appetite but fiber delivers stronger gut microbiome benefits

A randomized crossover weight loss trial in adults with overweight or obesity found that higher protein big breakfasts improved satiety, while higher fibre breakfasts produced slightly greater weight loss and more favourable gut microbiota markers. Both diets improved metabolic biomarkers, but microbiota changes reflected surrogate gut health indicators rather than direct clinical outcomes.

15 Feb 2026

Higher red meat intake links to greater diabetes odds in large US study

Higher intakes of total, processed, and unprocessed red meat were associated with greater odds of diabetes in a nationally representative sample of US adults. Statistical substitution models suggest replacing red meat with plant proteins, poultry, dairy, or whole grains may be linked to lower diabetes odds, though causality cannot be inferred.

15 Feb 2026

Role of food nutrients in reducing oxidative stress linked to micro- and nanoplastics

This narrative review examines how micro- and nanoplastics may contribute to oxidative stress, inflammation, and metabolic dysfunction, including potential links with diabetes. It highlights plant-derived nutrients that activate the Nrf2 pathway as a possible strategy to enhance cellular stress resilience, although most evidence remains preclinical.

15 Feb 2026

Glucose News and Research

Natural compound from pomegranate leaves shows promise against TTR amyloidosis

Researchers show red blood cells drive better glucose tolerance at high altitude

New review explores whether berries can slow cognitive decline linked to obesity

Affordable microscope captures living cells during chaotic conditions of zero-gravity flight

Should drug companies be advertising to consumers?

Low oxygen turns red blood cells into powerful glucose sinks

Hypoxia rewires red blood cells to clear excess glucose

Syzygium jambolanum extract shows promise for diabetes management

Gut microbiome may shape response to GLP-1 drugs, new review suggests

Gut bacteria patterns help predict insulin resistance in type 2 diabetes, study finds

Intermittent calorie restriction proves as effective as daily calorie cuts for type 2 diabetes

How GLP-1 drugs affect the body beyond weight loss and glucose control

Undiagnosed diabetes and kidney disease raise heart risk

Can GLP-1 drugs slow neurodegeneration? New review finds promising signals but limited clinical proof

Study links microbe-rich diets with better insulin and cholesterol markers

Do cocoa flavanols influence heart and fatty liver risk factors?

Machine learning model demonstrates insulin resistance as a risk factor for 12 types of cancer

Big breakfast study reveals protein curbs appetite but fiber delivers stronger gut microbiome benefits

Higher red meat intake links to greater diabetes odds in large US study

Role of food nutrients in reducing oxidative stress linked to micro- and nanoplastics

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News